# BrightView Holdings, Inc.: financial statements, quarterly BV · NYSE · CIK 1734713 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Sep 30 Pages: [Overview](/companies/bv.md) · [Financials](/companies/bv/financials.md) · [Filings](/companies/bv/filings.md) · [Insiders](/companies/bv/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bv/financials.md?period=annual). ## Income statement | Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [744 d](/filings/0001193125-25-288109.md) | [627](/filings/0000950170-25-014510.md) | [673](/filings/0000950170-25-065670.md) | [739](/filings/0000950170-25-104037.md) | [729 d](/filings/0001193125-25-288109.md) | [599](/filings/0001193125-26-035550.md) | [663](/filings/0001193125-26-206419.md) | [708](/filings/0001193125-26-332820.md) | [703 d](/filings/0001193125-25-288109.md) | [615](/filings/0001193125-26-035550.md) | [703](/filings/0001193125-26-206419.md) | [718](/filings/0001193125-26-332820.md) | | Cost of revenue | $m | [558 d](/filings/0001193125-25-288109.md) | [493](/filings/0000950170-25-014510.md) | [521](/filings/0000950170-25-065670.md) | [561](/filings/0000950170-25-104037.md) | [547 d](/filings/0001193125-25-288109.md) | [472](/filings/0001193125-26-035550.md) | [515](/filings/0001193125-26-206419.md) | [537](/filings/0001193125-26-332820.md) | [526 d](/filings/0001193125-25-288109.md) | [500](/filings/0001193125-26-035550.md) | [565](/filings/0001193125-26-206419.md) | [566](/filings/0001193125-26-332820.md) | | Gross profit | $m | [186 d](/filings/0001193125-25-288109.md) | [134](/filings/0000950170-25-014510.md) | [152](/filings/0000950170-25-065670.md) | [178](/filings/0000950170-25-104037.md) | [182 d](/filings/0001193125-25-288109.md) | [127](/filings/0001193125-26-035550.md) | [148](/filings/0001193125-26-206419.md) | [171](/filings/0001193125-26-332820.md) | [177 d](/filings/0001193125-25-288109.md) | [114](/filings/0001193125-26-035550.md) | [138](/filings/0001193125-26-206419.md) | [152](/filings/0001193125-26-332820.md) | | Selling, general and administrative | $m | [120 d](/filings/0001193125-25-288109.md) | [130](/filings/0000950170-25-014510.md) | [125](/filings/0000950170-25-065670.md) | [120](/filings/0000950170-25-104037.md) | [122 d](/filings/0001193125-25-288109.md) | [119](/filings/0001193125-26-035550.md) | [118](/filings/0001193125-26-206419.md) | [106](/filings/0001193125-26-332820.md) | [114 d](/filings/0001193125-25-288109.md) | [115](/filings/0001193125-26-035550.md) | [116](/filings/0001193125-26-206419.md) | [115](/filings/0001193125-26-332820.md) | | Operating income | $m | [54.4 d](/filings/0001193125-25-288109.md) | [(6.2)](/filings/0000950170-25-014510.md) | [62.2](/filings/0000950170-25-065670.md) | [49.0](/filings/0000950170-25-104037.md) | [51.9 d](/filings/0001193125-25-288109.md) | [(0.6)](/filings/0001193125-26-035550.md) | [22.3](/filings/0001193125-26-206419.md) | [57.6](/filings/0001193125-26-332820.md) | [55.2 d](/filings/0001193125-25-288109.md) | [(7.1)](/filings/0001193125-26-035550.md) | [16.1](/filings/0001193125-26-206419.md) | [32.3](/filings/0001193125-26-332820.md) | | Interest expense | $m | [19.1 d](/filings/0001193125-25-288109.md) | [17.1](/filings/0000950170-25-014510.md) | [16.0](/filings/0000950170-25-065670.md) | [15.1](/filings/0000950170-25-104037.md) | [14.2 d](/filings/0001193125-25-288109.md) | [14.2](/filings/0001193125-26-035550.md) | [12.8](/filings/0001193125-26-206419.md) | [13.4](/filings/0001193125-26-332820.md) | [13.4 d](/filings/0001193125-25-288109.md) | [13.5](/filings/0001193125-26-035550.md) | [13.7](/filings/0001193125-26-206419.md) | [14.9](/filings/0001193125-26-332820.md) | | Income tax | $m | [10.1 d](/filings/0001193125-25-288109.md) | [(5.7)](/filings/0000950170-25-014510.md) | [13.3](/filings/0000950170-25-065670.md) | [9.9](/filings/0000950170-25-104037.md) | [12.6 d](/filings/0001193125-25-288109.md) | [(4.2)](/filings/0001193125-26-035550.md) | [2.3](/filings/0001193125-26-206419.md) | [12.6](/filings/0001193125-26-332820.md) | [14.6 d](/filings/0001193125-25-288109.md) | [(5.2)](/filings/0001193125-26-035550.md) | [0.6](/filings/0001193125-26-206419.md) | [2.3](/filings/0001193125-26-332820.md) | | Net income | $m | [16.4 d](/filings/0001193125-25-288109.md) | [(16.4)](/filings/0000950170-25-014510.md) | [33.7](/filings/0000950170-25-065670.md) | [23.5](/filings/0000950170-25-104037.md) | [25.6 d](/filings/0001193125-25-288109.md) | [(10.4)](/filings/0001193125-26-035550.md) | [6.4](/filings/0001193125-26-206419.md) | [32.3](/filings/0001193125-26-332820.md) | [27.7 d](/filings/0001193125-25-288109.md) | [(15.2)](/filings/0001193125-26-035550.md) | [1.7](/filings/0001193125-26-206419.md) | [6.1](/filings/0001193125-26-332820.md) | | Diluted EPS | $ per share | not reported | [(0.27)](/filings/0000950170-25-014510.md) | [0.17](/filings/0000950170-25-065670.md) | [0.10](/filings/0000950170-25-104037.md) | not reported | [(0.20)](/filings/0001193125-26-035550.md) | [(0.03)](/filings/0001193125-26-206419.md) | [0.15](/filings/0001193125-26-332820.md) | not reported | [(0.26)](/filings/0001193125-26-035550.md) | [(0.08)](/filings/0001193125-26-206419.md) | [(0.03)](/filings/0001193125-26-332820.md) | | Basic EPS | $ per share | not reported | [(0.27)](/filings/0000950170-25-014510.md) | [0.17](/filings/0000950170-25-065670.md) | [0.10](/filings/0000950170-25-104037.md) | not reported | [(0.20)](/filings/0001193125-26-035550.md) | [(0.03)](/filings/0001193125-26-206419.md) | [0.16](/filings/0001193125-26-332820.md) | not reported | [(0.26)](/filings/0001193125-26-035550.md) | [(0.08)](/filings/0001193125-26-206419.md) | [(0.03)](/filings/0001193125-26-332820.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [67.0](/filings/0000950170-24-126338.md) | [64.5](/filings/0000950170-24-009414.md) | [177](/filings/0000950170-24-051292.md) | [116](/filings/0000950170-24-088585.md) | [140](/filings/0001193125-25-288109.md) | [98.3](/filings/0000950170-25-014510.md) | [141](/filings/0000950170-25-065670.md) | [79.1](/filings/0000950170-25-104037.md) | [74.5](/filings/0001193125-26-332820.md) | [37.0](/filings/0001193125-26-035550.md) | [10.1](/filings/0001193125-26-206419.md) | [14.4](/filings/0001193125-26-332820.md) | | Current assets | $m | [742](/filings/0000950170-24-126338.md) | [691](/filings/0000950170-24-009414.md) | [799](/filings/0000950170-24-051292.md) | [760](/filings/0000950170-24-088585.md) | [780](/filings/0001193125-25-288109.md) | [686](/filings/0000950170-25-014510.md) | [716](/filings/0000950170-25-065670.md) | [665](/filings/0000950170-25-104037.md) | [666](/filings/0001193125-26-332820.md) | [599](/filings/0001193125-26-035550.md) | [630](/filings/0001193125-26-206419.md) | [610](/filings/0001193125-26-332820.md) | | Total assets | $m | [3,352](/filings/0000950170-24-126338.md) | [3,264](/filings/0000950170-24-009414.md) | [3,362](/filings/0000950170-24-051292.md) | [3,363](/filings/0000950170-24-088585.md) | [3,392](/filings/0001193125-25-288109.md) | [3,308](/filings/0000950170-25-014510.md) | [3,325](/filings/0000950170-25-065670.md) | [3,357](/filings/0000950170-25-104037.md) | [3,392](/filings/0001193125-26-332820.md) | [3,316](/filings/0001193125-26-035550.md) | [3,373](/filings/0001193125-26-206419.md) | [3,412](/filings/0001193125-26-332820.md) | | Current liabilities | $m | [467](/filings/0000950170-24-126338.md) | [421](/filings/0000950170-24-009414.md) | [477](/filings/0000950170-24-051292.md) | [525](/filings/0000950170-24-088585.md) | [543](/filings/0001193125-25-288109.md) | [479](/filings/0000950170-25-014510.md) | [505](/filings/0000950170-25-065670.md) | [509](/filings/0000950170-25-104037.md) | [515](/filings/0001193125-26-332820.md) | [476](/filings/0001193125-26-035550.md) | [512](/filings/0001193125-26-206419.md) | [476](/filings/0001193125-26-332820.md) | | Total liabilities | $m | [1,611](/filings/0000950170-24-126338.md) | [1,548](/filings/0000950170-24-009414.md) | [1,611](/filings/0000950170-24-051292.md) | [1,592](/filings/0000950170-24-088585.md) | [1,609](/filings/0001193125-25-288109.md) | [1,535](/filings/0000950170-25-014510.md) | [1,556](/filings/0000950170-25-065670.md) | [1,571](/filings/0000950170-25-104037.md) | [1,592](/filings/0001193125-26-332820.md) | [1,555](/filings/0001193125-26-035550.md) | [1,625](/filings/0001193125-26-206419.md) | [1,670](/filings/0001193125-26-332820.md) | | Long-term debt | $m | [888](/filings/0000950170-24-126338.md) | [880](/filings/0000950170-24-009414.md) | [880](/filings/0000950170-24-051292.md) | [807](/filings/0000950170-24-088585.md) | [803](/filings/0001193125-25-288109.md) | [797](/filings/0000950170-25-014510.md) | [799](/filings/0000950170-25-065670.md) | [791](/filings/0000950170-25-104037.md) | [790](/filings/0001193125-26-332820.md) | [801](/filings/0001193125-26-035550.md) | [824](/filings/0001193125-26-206419.md) | [875](/filings/0001193125-26-332820.md) | | Current portion of debt | $m | [0.0](/filings/0000950170-24-126338.md) | [0.0](/filings/0000950170-24-009414.md) | [0.0](/filings/0000950170-24-051292.md) | [0.0](/filings/0000950170-24-088585.md) | [0.0](/filings/0001193125-25-288109.md) | [0.0](/filings/0000950170-25-014510.md) | [0.0](/filings/0000950170-25-065670.md) | [0.0](/filings/0000950170-25-104037.md) | [0.0](/filings/0001193125-26-332820.md) | [0.0](/filings/0001193125-26-035550.md) | [0.0](/filings/0001193125-26-206419.md) | [7.4](/filings/0001193125-26-332820.md) | | Shareholders' equity | $m | [1,243](/filings/0001193125-25-288109.md) | [1,208](/filings/0000950170-25-065670.md) | [1,244](/filings/0000950170-25-104037.md) | [1,264](/filings/0000950170-25-104037.md) | [1,275](/filings/0001193125-26-332820.md) | [1,266](/filings/0001193125-26-206419.md) | [1,261](/filings/0001193125-26-332820.md) | [1,280](/filings/0001193125-26-332820.md) | [1,293](/filings/0001193125-26-332820.md) | [1,254](/filings/0001193125-26-206419.md) | [1,241](/filings/0001193125-26-332820.md) | [1,235](/filings/0001193125-26-332820.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [40.6 d](/filings/0001193125-25-288109.md) | [26.2](/filings/0000950170-25-014510.md) | [83.3 d](/filings/0000950170-25-065670.md) | [42.6 d](/filings/0000950170-25-104037.md) | [53.5 d](/filings/0001193125-25-288109.md) | [60.5](/filings/0001193125-26-035550.md) | [91.2 d](/filings/0001193125-26-206419.md) | [55.7 d](/filings/0001193125-26-332820.md) | [84.4 d](/filings/0001193125-25-288109.md) | [36.1](/filings/0001193125-26-035550.md) | [46.2 d](/filings/0001193125-26-206419.md) | [46.0 d](/filings/0001193125-26-332820.md) | | Capital expenditure | $m | [13.4 d](/filings/0001193125-25-288109.md) | [10.1](/filings/0000950170-25-014510.md) | [12.6 d](/filings/0000950170-25-065670.md) | [23.3 d](/filings/0000950170-25-104037.md) | [32.4 d](/filings/0001193125-25-288109.md) | [58.7](/filings/0001193125-26-035550.md) | [33.6 d](/filings/0001193125-26-206419.md) | [104 d](/filings/0001193125-26-332820.md) | [58.4 d](/filings/0001193125-25-288109.md) | [54.7](/filings/0001193125-26-035550.md) | [58.8 d](/filings/0001193125-26-206419.md) | [65.3 d](/filings/0001193125-26-332820.md) | | Share repurchases | $m | [0.9 d](/filings/0001193125-25-288109.md) | [2.5](/filings/0000950170-25-014510.md) | [0.0 d](/filings/0000950170-25-065670.md) | [0.6 d](/filings/0000950170-25-104037.md) | [0.0 d](/filings/0001193125-25-288109.md) | [5.1](/filings/0001193125-26-035550.md) | [1.7 d](/filings/0001193125-26-206419.md) | [7.7 d](/filings/0001193125-26-332820.md) | [9.7 d](/filings/0001193125-25-288109.md) | [18.8](/filings/0001193125-26-035550.md) | [14.4 d](/filings/0001193125-26-206419.md) | [9.6 d](/filings/0001193125-26-332820.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [93.3](/filings/0000950170-24-009414.md) | [93.5](/filings/0000950170-24-051292.md) | [94.0](/filings/0000950170-24-088585.md) | [94.0](/filings/0000950170-25-014510.md) | [95.7](/filings/0000950170-25-065670.md) | [96.7](/filings/0000950170-25-104037.md) | [95.2](/filings/0001193125-26-035550.md) | [95.5](/filings/0001193125-26-206419.md) | [97.7](/filings/0001193125-26-332820.md) | [94.7](/filings/0001193125-26-035550.md) | [94.0](/filings/0001193125-26-206419.md) | [93.1](/filings/0001193125-26-332820.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 92,600,000 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001193125-26-332820.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.